Skip to content
Sign in
Artwork for Neurology® Podcast
Health & FitnessMedicineScience

Neurology® Podcast

American Academy of Neurology

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Play
Open in
  • 27 episodes
  • a few times a week
  • Avg 26 min
  • English

Episodes 27

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • Wednesday · 1 hr 7 min

    September 2026 Recall: Updates in Child Neurology

    The September 2026 Recall features four previously posted episodes highlighting updates in child neurology. The episode begins with Dr. Andrew Hershey discussing advances in the treatment of pediatric migraines. Next, Dr. Serena Orr discusses the genetic risk of migraine and post-traumatic headache in children. In the third episode, Dr. Coral Stredny reviews the management of pediatric convulsive status epilepticus, with a focus on seizure action plans and adherence to treatment protocols. The episode concludes with Dr. Scott Perry discussing approaches to improving the transition from pediatric to adult epilepsy care. Podcast links: Fremanezumab in Children and Adolescents with Episodic Migraine Post-Traumatic Headache in Children and Genetic Risk of Migraine Seizure Action Plans in Pediatric Convulsive Status Epilepticus Navigating the Transition From Pediatric to Adult Epilepsy Care Article links: Fremanezumab in Children and Adolescents with Episodic Migraine Post-Traumatic Headache in Children and Genetic Risk of Migraine Assessment of Seizure Action Plans in Pediatric Convulsive Status Epilepticus Addressing Barriers to Transitioning Pediatric Patients With Epilepsy to Adult Health Care in the United States Disclosures can be found at Neurology.org.

  • August 27 · 12 min

    2026 Alzheimer Association International Conference - Part 2

    In part two of this series on the 2026 Alzheimer Association International Conference, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about recent clinical trials, evolving treatment strategies, and prevention efforts. Disclosures can be found at Neurology.org.

  • August 24 · 16 min

    2026 Alzheimer Association International Conference - Part 1

    In part one of this series, Dr. Greg Cooper talks with Drs. Trey Bateman and Gregg Day about blood-based biomarkers, anti-amyloid therapies, and other highlights from the 2026 Alzheimer Association International Conference. Disclosures can be found at Neurology.org.

  • August 20 · 24 min

    The Relationship Between Age and Recovery After Spinal Cord Injury

    Dr. Shuvro Roy talks with Prof. Catherine Jutzeler about how age influences neurologic and functional recovery after spinal cord injury and how these findings could inform treatment and future clinical trials. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

  • August 17 · 19 min

    Virtual vs In-Person Neurologic Ambulatory Care

    Dr. Greg Cooper talks with Dr. Chloe Hill about comparing virtual and in-person neurology outpatient visits for new patients. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

  • August 13 · 19 min

    American Epilepsy Society Clinical Practice Guideline

    Dr. Dara Albert talks with Dr. Daniel Freedman about the new practice guideline from the American Epilepsy Society on infantile epilepsy, highlighting key findings on medication, dietary therapy, and the importance of early surgical intervention for infants with epilepsy. Read the related guideline here. Disclosures can be found at Neurology.org.

  • August 3 · 22 min

    Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA

    Dr. Elizabeth Coon talks with Dr. Lucy Norcliffe-Kaufmann about the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

  • August 1 · 1 hr 50 min

    August 2026 Recall: Topics in Headache

    The August 2026 recall showcases five incredible interviews highlighting recent advances in headache medicine. The episode begins with Dr. Patricia Pozo-Rosich discussing the latest advancements in headache medicine, focusing on key research findings from 2025. The episode continues with Dr. Jennifer Robblee discussing the latest consensus on refractory migraine. In the third episode of this series, Dr. Michael Eller discusses the implications of CGRP therapies in migraine treatment. The recall concludes with a two-part discussion featuring Drs. Tesha Monteith and Peter Goadsby, who highlight major developments in headache medicine presented at the 2026 AAN Annual Meeting. Podcast links: The Best of Headache Medicine from 2025: A Year in Review Refractory Headache Disorders, New Consensus, and Emergency Department Migraine Guidelines CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 1 Headache Medicine Highlights from the 2026 AAN Annual Meeting - Part 2 Article links: Reaching International Consensus on the Definition of Refractory Migraine Using the Delphi Method 2025 Guideline Update to Acute Treatment of Migraine for Adults in the Emergency Department CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke Disclosures can be found at Neurology.org.

  • July 30 · 20 min

    Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2

    In part two of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about the latest developments in BTK inhibitors for MS, including safety signals, trial results, and future directions. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial. Disclosures can be found at Neurology.org.

  • July 27 · 26 min

    Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1

    In part one of this series, Dr. Shuvro Roy talks with Drs. Jiwon Oh and Amit Bar-Or about recent multiple sclerosis clinical trial data. For more information, please read about the abstract that was presented at the 2026 AAN Annual Meeting. Read more about the Fenebrutinib Trial. Disclosures can be found at Neurology.org.

  • July 23 · 24 min

    2026 International Conference on Functional Neurological Disorder

    Dr. Dara Albert talks with Dr. Jon Stone about the latest advancements in FND from the recent International Conference on Functional Neurological Disorder. Dr. Jon Stone shares insights on the field's growth, multidisciplinary care, cultural perspectives, and future directions. Check out the FNDS website for more information about FND. Disclosures can be found at Neurology.org.

  • July 13 · 17 min

    When Drug Marketing Masquerades as Clinical Trials

    Dr. Justin Abbatemarco talks with Sukhun Kang about seeding trials and other hidden marketing tactics in clinical trials, and their implications for clinical practice and patient care. Read the related article on The Conversation. Disclosures can be found at Neurology.org.

  • July 9 · 30 min

    Neurology® at 75: The Evolution of the Neurology Journal

    To celebrate 75 years of Neurology®, Dr. Chris Boes talks with Dr. José Merino about the journal's history, its evolution, and what lies ahead for the future of Neurology®. Read more about the first 75 years of Neurology®. Disclosures can be found at Neurology.org.

Showing 1–20 of 27 episodes